Document Detail

An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
MedLine Citation:
PMID:  21385145     Owner:  NLM     Status:  Publisher    
Abstract Objective: To compare the efficacy, in the prevention of venous thromboembolism (VTE), and safety, of rivaroxaban and dabigatran relative to the common comparator enoxaparin. Methods: Two randomized clinical trials of dabigatran, one after total hip replacement (THR), RE-NOVATE, and one after total knee replacement (TKR), RE-MODEL, were identified as using the same enoxaparin regimen (40 mg once daily given the evening before surgery) and being of comparable duration to two rivaroxaban trials, RECORD1 and RECORD3. Indirect comparisons were performed on both efficacy and safety endpoints. To enable comparisons, symptomatic VTE results were based on the total study duration period, i.e. including the follow-up period. Major bleeding included surgical-site bleeding events. Results: After THR, rivaroxaban 10 mg once daily significantly reduced total VTE and symptomatic VTE relative to dabigatran 220 mg once daily (relative risk 0.34 and 0.19, respectively). After TKR, rivaroxaban significantly reduced total VTE versus dabigatran (relative risk 0.53); symptomatic VTE was not different between dabigatran and rivaroxaban. There was no significant difference in the rates of major bleeding for patients receiving rivaroxaban or dabigatran. Conclusions: Based on the indirect comparisons, rivaroxaban was estimated to be more efficacious than dabigatran in the prevention of total VTE after THR and TKR. Our analysis relied upon published data for dabigatran and did not have the advantages of more detailed comparative data obtained directly from a randomized trial, as was the case with rivaroxaban. Further comparative research may be of value, but until available our conclusions represent the best available evidence.
Corinne Lereun; Phillip Wells; Alex Diamantopoulos; Farhat Rasul; Michael Lees; Nishan Sengupta
Related Documents :
15840115 - Chronic actinic dermatitis treated with mycophenolate mofetil.
17642785 - Varicella-induced remission of steroid-resistant nephrotic syndrome in a child.
23563735 - Treatment of the residual cavity during hepatic hydatidosis surgery: a cohort study of ...
24491005 - Zinc supplement in reduction of relapses in children with steroid sensitive nephrotic s...
20224465 - Positive response to intravitreal ranibizumab in the treatment of choroidal neovascular...
23744795 - Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome acc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-9
Journal Detail:
Title:  Journal of medical economics     Volume:  -     ISSN:  1941-837X     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9892255     Medline TA:  J Med Econ     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Carrigaline, County Cork, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease...
Next Document:  The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activ...